Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · JLHL

JLHL

HealthcareHealthcare Services₹9494 cr market cap
₹280.80 ▼ -3.04% today As of 19 Nov 2026
52-week low ₹239.6552-week high ₹332.40

-12.9% from the 52-week high · +20.8% above the low

Jupiter Life Line Hospitals Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Thane, Maharashtra. The company went IPO on 2023-09-18. Jupiter Life Line Hospitals Limited is an India-based holding company. The firm is engaged in providing services in the field of healthcare and related services. The firm has a total bed capacity of approximately 1,194 hospital beds across three hospitals. The firm operates three hospitals under the Jupiter brand in Thane, Pune, and Indore, with an operational bed capacity (census and non-census beds) of 950 beds and 900 beds, and over 1,246 doctors, including specialists, physicians, and surgeons. The company is also focused on developing a multi-specialty hospital in Dombivli, Maharashtra. The Company’s subsidiaries include Jupiter Hospitals Projects Private Limited and Medulla Healthcare Private Limited.

The short version. JLHL reported revenue of ₹456 crore for Sep 2026, up 15.7% from a year earlier. Net profit was ₹56 crore (down 1.8% year on year). Return on equity was 12.9% in Mar 2026. Promoter holding was 40.91% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

JLHL trades 12.9% below its 52-week high and 20.8% above its 52-week low.

Change over period: —

1M+18.7%
3M-9.7%
6M+9.8%
1Y+1.0%

2 · The business

Is it growing?

Sales, year on year+15.7%

Sep 2026 revenue of ₹456 cr.

Profit, year on year-1.8%

Sep 2026 net profit of ₹56 cr.

Net margin12.3%

2.3 pts lower than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue456411388365394348327321
Net profit5637494357444553
Net margin %12.39.112.611.614.612.613.716.4
EPS (₹)1.711.141.491.31.751.341.371.6

Annual

FY2026FY2025FY2024
Revenue150012621070
Net profit199193177
Net margin %13.315.316.5
EPS (₹)6.075.895.39

3 · The quality

How well does it turn capital into profit?

Return on equity was 12.9% in Mar 2026; debt to equity is 0.33.

Profitability · 3 years

Returns and margins

Mar 2026Mar 2025Mar 2024
Return on equity %12.914.215.1
Return on capital %13.815.318.9
EBITDA margin %25.025.224.1
Net margin %12.915.016.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.33
Interest cover9.1x
Current ratio3.02
P/E ratio51.0

4 · The owners

Who holds it, and are they adding?

Promoter holding40.91%

Unchanged over 8 quarters.

Foreign institutions9.13%

Down 0.91 pts over 8 quarters.

Domestic institutions19.13%

Up 3.39 pts over 8 quarters.

Mutual fund schemes33

+12 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter40.9140.9140.9140.9140.9140.9140.9140.910.0
FII10.0410.039.779.068.488.489.379.13-0.91
DII15.7415.6315.8216.9517.4317.0116.5119.13+3.39
Public33.333.4233.533.0833.1733.633.2130.83-2.47

Mutual fund holdings · Oct 2026

33 schemes hold this stock

21 the month before.

  • ICICI Prudential Life Cycle Fund 20362.69% of NAV
  • Groww BSE Hospitals ETF2.25% of NAV
  • UTI - Healthcare Fund2.24% of NAV
  • SBI MultiCap Fund2.18% of NAV
  • SBI Healthcare Opportunities Fund2.12% of NAV
  • ICICI Prudential Life Cycle Fund 20411.96% of NAV
  • THE WEALTH COMPANY SMALL CAP FUND1.91% of NAV
  • HDFC Consumption Fund1.72% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for JLHL are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about JLHL

What is the JLHL share price?

JLHL (JLHL) last closed at ₹280.80, down 3.04% on the day. Its 52-week range is ₹239.65 to ₹332.40.

What is the market cap of JLHL?

JLHL has a market capitalisation of about ₹9,494 crore. Its price-to-earnings ratio is 51.0.

How are JLHL's latest results?

JLHL reported revenue of ₹456 crore for Sep 2026, up 15.7% from a year earlier. Net profit was ₹56 crore (down 1.8% year on year). Return on equity was 12.9% in Mar 2026. Promoter holding was 40.91% in Sep 2026, up 0.00 points over 8 quarters.

Who owns JLHL?

As of Sep 2026, shareholding was: Promoter 40.91%, FII 9.13%, DII 19.13%, Public 30.83%.

How many mutual funds hold JLHL?

33 mutual fund schemes held JLHL in October 2026. That compares with 21 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 22 May 2026 · Interim Dividend - Rs. 1
  • 04 Jul 2025 · Final Dividend - Rs. 1
  • 02 Aug 2024 · Final Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.